Qualitative and Quantitative Evaluation of Vascular Flows of Radial, Ulnar and Interdigital Arterial Trees Under Normal and Pathological Conditions by 3 Tesla MRI

NCT04257747 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 46

Last updated 2025-06-10

No results posted yet for this study

Summary

Allotransplants of vascularized composite tissues are subject to chronic vascular rejection, which can lead to graft loss. Currently, no imaging technique allows a reproducible quantitative exploration of the arterial trees of the hand, and therefore a satisfactory monitoring of transplants. Since 2014, flow MRI has been applied to the analysis of small-calibre arteries by the Image Processing Team at the Amiens-Picardie University Hospital. Between 2015 and 2017, several acquisitions were made in 3 patients who received facial allotransplantation, and the team recently developed a flow MRI protocol dedicated to the study of arterial trees in the hand.

The main objective is to measure vascular flows of radial, ulnar and interdigital arterial trees in normal (healthy volunteers) and pathological situations (patients with radial forearm flap reconstruction and patients with hand allotransplantation) using the specifically developed flow MRI protocol.

Conditions

  • Magnetic Resonance Imaging
  • Vascular Complications
  • Transplantation
  • Radial Artery

Interventions

OTHER

MRI acquisitions

MRI acquisitions will be performed on the ACHIEVA 3T TX DStream Philips® Research MRI of the GIE Faire Faces.

OTHER

Doppler ultrasound procedure

The Doppler ultrasound procedure will be conducted in the traditional way in the Vascular Medicine Department of the Amiens-Picardie University Hospital

Sponsors & Collaborators

  • Hôpital Edouard Herriot

    collaborator OTHER
  • Centre Hospitalier Universitaire, Amiens

    lead OTHER

Principal Investigators

  • Stéphanie Dakpe, MD · CHU Amiens

  • Jérémie Bettoni, MD · CHU Amiens

  • Olivier Baledent, MD · CHU Amiens

  • Marie-Antoinette Sevestre-Pietri, Pr · CHU Amiens

  • Emmanuel Morelon, Pr · Hopital Edouard Herriot

  • Palmira Petruzzo, MD · Hopital Edouard Herriot

Study Design

Allocation
NON_RANDOMIZED
Purpose
OTHER
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2021-09-01
Primary Completion
2028-05-31
Completion
2029-03-31

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04257747 on ClinicalTrials.gov